Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Anim Physiol Anim Nutr (Berl) ; 107(4): 1125-1136, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36876872

RESUMO

Effects of dietary Euphorbia heterophylla extract (EH) on growth performance, feed utilization and haemato-biochemical parameters in African catfish, Clarias gariepinus, juveniles were evaluated in this study. Diets fortified with EH at 0 (control), 0.5, 1.0, 1.5 or 2.0 g/kg were fed to the fish to apparent satiation for 84 days before challenging it with Aeromonas hydrophila. The weight gain, specific growth rate and protein efficiency ratio of fish fed EH-supplemented diets were significantly higher but lower feed conversion ratio (p < 0.05) than the control group. The villi height and width at the proximal, mid and the distal of the guts rose significantly with the increasing levels of EH from 0.5 to 1.5 g than the fish fed basal diet. Dietary EH enhanced (p < 0.05) the packed cell volume and haemoglobin, whereas 1.5 g EH boosted white blood cell, in relation to their counterpart in the control group. There were significant increase in the activities of glutathione-S-transferase, glutathione peroxidase and superoxide dismutase (p < 0.05) in the fish that were fed diets supplemented with EH than the control. Dietary EH also enhanced phagocytic activities, lysozyme activities and relative survival (RS) of C. gariepinus than the control group, with the highest RS obtained in fish that were fed diet containing EH at 1.5 g/kg level. These results revealed that the fish fed 1.5 g/kg dietary EH promoted growth performance, antioxidant and immune profiles, as well as protection against A. hydrophila infection.


Assuntos
Peixes-Gato , Euphorbia , Doenças dos Peixes , Infecções por Bactérias Gram-Negativas , Animais , Antioxidantes/metabolismo , Euphorbia/metabolismo , Dieta/veterinária , Suplementos Nutricionais , Resistência à Doença , Extratos Vegetais/farmacologia , Ração Animal/análise , Doenças dos Peixes/prevenção & controle , Infecções por Bactérias Gram-Negativas/prevenção & controle , Infecções por Bactérias Gram-Negativas/veterinária
2.
Pak J Pharm Sci ; 35(6): 1581-1694, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36789818

RESUMO

Launaea taraxacifolia has been traditionally used for the management of conditions such as cardiovascular, respiratory, and metabolic diseases. High blood pressure was established by oral administration of L-Nitro Arginine Methyl Ester (L-NAME) a non-selective inhibitor of endothelial nitric oxide synthase (eNOS). The antihypertensive action of the methanol leaf extract of L. taraxacifolia was examined. Fifty male Wistar rats were divided into 5 groups of 10 animals per group: Group A (Distilled water), Group B (Hypertensive rats; 40mg/kg L-NAME), Group C (Hypertensive rats plus 100mg/kg extract), Group D (Hypertensive rats plus 200 mg/kg extract) and Group E (Hypertensive rats plus 10mg/kg of Lisinopril). The treatments were orally administered for five weeks. Haemodynamic parameters, urinalysis, indices of oxidative stress and immunohistochemistry were determined. Findings from this study showed that blood pressure parameters, urinary sodium and indices of oxidative stress increased significantly while In-vivo antioxidant defence systems decreased significantly in hypertensive rats. Immunohistochemistry revealed significant increases in expressions of mineralocorticoid receptor, angiotensin converting enzyme activity and kidney injury molecule-1 in kidney of hypertensive rats. Treatment with Launeae taraxacifolia normalized blood pressure parameters, urinary sodium, oxidative stress indices, antioxidant defence system, and serum nitric oxide bioavailability.


Assuntos
Anti-Hipertensivos , Asteraceae , Hipertensão , Extratos Vegetais , Animais , Masculino , Ratos , Anti-Hipertensivos/farmacologia , Antioxidantes/farmacologia , Pressão Sanguínea , Hipertensão/tratamento farmacológico , Hipertensão/metabolismo , NG-Nitroarginina Metil Éster , Óxido Nítrico/metabolismo , Estresse Oxidativo , Ratos Wistar , Sódio , Extratos Vegetais/farmacologia
3.
J Food Biochem ; 44(12): e13534, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-33089540

RESUMO

Hypertension is the most common cardiovascular disease that affects approximately 26% of adult population, worldwide. Rutin is one of the important flavonoids that is consumed in the daily diet, and found in many food items, vegetables, and beverages. Uninephrectomy (UNX) of the left kidney was performed, followed by induction of hypertension. The rats were randomly divided into four groups of 10 rats: group 1-Sham-operated rats; group 2-UNX rats, group 3-UNX-L-NAME (40 mg/kg) plus rutin (100 mg/kg bwt), and groups 4-UNX-L-NAME plus lisinopril (10 mg/kg bwt), orally for 3 weeks. Results revealed significant heightening of arterial pressure and oxidative stress indices, while hypertensive rats treated with rutin had lower expressions of angiotensin converting enzyme (ACE) and mineralocorticoid receptor in uninephrectomized rats. Together, rutin as a novel antihypertensive flavonoid could provide an unimaginable benefits for the management of hypertension through inhibition of angiotensin converting enzyme and mineralocorticoid receptor. PRACTICAL APPLICATIONS: Hypertension has been reported to be the most common cardiovascular disease, affecting approximately 26% of the adult population worldwide with predicted prevalence to increase by 60% by 2025. Recent advances in phytomedicine have shown flavonoids to be very helpful in the treatment of many diseases. Flavonoids have been used in the treatment and management of cardiovascular diseases, obesity and hypertension. The study revealed that rutin, a known flavonoid inhibited angiotensin converting enzyme (ACE), angiotensin 2 type 1 receptor (ATR1), and mineralocorticoid receptor (MCR), comparable to the classic ACE inhibitor, Lisinopril, indicating the novel antihypertensive property of rutin. Therefore, flavonoids such as rutin found in fruits and vegetables could, therefore, serve as an antihypertensive drug regimen. Combining all, functional foods rich in flavonoids could be used as potential therapeutic candidates for managing uninephrectomized hypertensive patients.


Assuntos
Anti-Hipertensivos , Hipertensão , Angiotensina II , Animais , Anti-Hipertensivos/farmacologia , Anti-Hipertensivos/uso terapêutico , Humanos , Hipertensão/tratamento farmacológico , Peptidil Dipeptidase A , Ratos , Receptores de Mineralocorticoides , Rutina/farmacologia , Rutina/uso terapêutico
4.
Environ Toxicol Pharmacol ; 80: 103488, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32898663

RESUMO

Cobalt-induced cardiomyopathy and renal toxicity have been reported in workers in processing plants, hard metal industries, diamond polishing and manufacture of ceramics. This study was designed to investigate the influence of Luteolin supplementation on cobalt-induced cardiac and renal toxicity in rats. Exposure of rats to cobalt chloride (CoCl2) alone caused significant (p < 0.05) increases in cardiac and renal H2O2, malondialdehyde (MDA) and nitric oxide (NO), along with increased serum myeloperoxidase (MPO) activity. In addition, there were significant (p < 0.05) reductions in cardiac and renal glutathione peroxidase (GPx), glutathione S-transferase (GST) and reduced glutathione (GSH). CoCl2 induced higher immuno-staining of nuclear factor kappa beta (NF-κB) in the heart and kidneys, and the kidney injury molecule (Kim-1) in the kidneys. Treatment with Luteolin or Gallic acid produced significant reversal of the oxidative stress parameters with reductions in NF-κB and Kim-1 expressions, leading to suppression of histopathological lesions observed in the tissues.


Assuntos
Injúria Renal Aguda/tratamento farmacológico , Anti-Inflamatórios/uso terapêutico , Cobalto/toxicidade , Suplementos Nutricionais , Ácido Gálico/uso terapêutico , Luteolina/uso terapêutico , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/metabolismo , Injúria Renal Aguda/patologia , Animais , Anti-Inflamatórios/farmacologia , Moléculas de Adesão Celular/metabolismo , Ácido Gálico/farmacologia , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Luteolina/farmacologia , Masculino , Miocárdio/metabolismo , Miocárdio/patologia , NF-kappa B/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Ratos Wistar , Transdução de Sinais/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA